Pfizer to put NJ complex up for sale; Impax says FDA flagged more manufacturing issues;

@FiercePharma: Longtime Roche chairman Franz Humer is stepping aside. Who's up next? More | Follow @FiercePharma

@EricPFierce: Pfizer building a plant in Saudi Arabia as MENA area becomes of more interest to Big Pharma. Story | Follow @EricPFierce

> Pfizer ($PFE) plans to unload a set of buildings in Madison, NJ, as its animal health unit, Zoetis, prepares to vacate the 500,000-square-foot property. Report

> Generics maker Impax Laboratories ($IPXL) has failed to bring some of its manufacturing operations back up to snuff in the FDA's eyes, and now faces another list of fixes to make at its Hayward, CA, plant. Report

> Researchers found that anti-TNF drugs for rheumatoid arthritis and other inflammatory conditions don't appear to increase the risk of shingles. Report

> A New Jersey judge rejected a recusal request from Roche's ($RHHBY) lawyers in the ongoing litigation over its acne drug Accutane. Report

> GlaxoSmithKline ($GSK) is preparing to relaunch a direct-sales program for some of its consumer health products. Report

Medical Device News

 @FierceMedDev: Report: Life Tech may have found a buyer after all. Story | Follow @FierceMedDev

 @MarkHFierce: Royalty financing may not be new, but it's novel for the medical device world. More | Follow @MarkHFierce

 @DamianFierce: Boston Scientific is holding back some data on Watchman, and market watchers are a little spooked. Report | Follow @DamianFierce

> GI Dynamics revs up anti-obesity device for Brazilian market. Item

> Saladax secures $22.4M from Chinese pharma giant. Report

Biotech News

 @FierceBiotech: Popular yesterday: Theravance: Biotech's big coming-of-age story. Editor's Corner | Follow @FierceBiotech

@JohnCFierce: TauRx adds $10.5M to its unconventional trove of Alzheimer's PhIII cash. News | Follow @JohnCFierce

@RyanMFierce: Engineering issues have stymied the mini DNA sequencer from Oxford Bio. Blogger says the tech chief is angry: Report | Follow @RyanMFierce

> Japan's Ajinomoto pounces on Althea Tech in $175M buyout deal. News

> TauRx adds $10.5M to its trove of unconventional Alzheimer's PhIII cash. Story

> Teva retrenches on troubled MS blockbuster hopeful as partner grabs $43M. More

> Antibiotics outfit Tetraphase offers price range for $75M biotech IPO. Article

Biomarkers News

> Advanced Cell Diagnostics enables cancer immunotherapy biomarker work. Story

> Australian team builds depression blood test around quinolinic acid. More

> Biomarker shines a light on new pathway to target neuroblastoma. Report

> Scripps scientists spot tropical disease marker in urine. Article

> Ignyta, Lieden University team on RA biomarker research. Item

Drug Delivery News

@MichaelGFierce: Yale researchers improve lupus drug with nanogel delivery. More | Follow @MichaelGFierce

> Actium BioSystems puts the heat on cancer with hyperthermic delivery. Report

> Mercator micro-infusion drug delivery catheter snags CE mark. News

> Combo drug, Dx nanomedicine deliver cancer-fighting payload. Article

> West launches intradermal adapter for shallow injections. Item

And Finally... The Centers for Disease Control and Prevention warn that certain bacteria are resistant even to the strongest available antibiotics, and the rate of infections in U.S. hospitals is growing. Report

Suggested Articles

AbbVie and Allergan were already jumping through hoops for their merger before a new tax added hundreds of millions to the cost.

Avastin and Herceptin saw U.S. slowdown that's “not very pronounced” after bioisim launched, but Roche execs still warn of "a significant impact.…

Novo Nordisk, which recently completed a wastewater treatment plant for its massive U.S. API site, has made a gift of the $40 million facility.